CNIO - Spanish National Cancer Research Centre
Marta Contreras Alcalde is a Ph.D. research professional currently engaged in two significant projects, serving at the CNIO - Spanish National Cancer Research Centre and as an Early Stage Researcher with the Immutrain Training Network for the Immunotherapy of Cancer. The academic background includes a Master's degree in Biomedical Sciences from Leiden University and a dual licenciatura in Biotechnology and Business Administration from Universidad Francisco de Vitoria. Prior experience encompasses a traineeship at INSERM focusing on telomeres and their role in genome stability and cancer, research internships at to-BBB Technologies BV and Albert Einstein College of Medicine, as well as a research internship at UPM-INIA studying starch metabolism enzymes. This extensive experience positions Marta as a knowledgeable contributor in the fields of cancer research and biotechnology.
This person is not in the org chart
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.